Provider review
Revel Health review
Pricing is shown openly on the homepage — no quiz-gating required
Semaglutide is $99 the first month then $199; tirzepatide $149 then $249, with NAD+ and sermorelin alongside — all published openly on the homepage. It serves 45 states and names the five it cannot, and refunds fully if a physician declines you.
Straight talk: how we earn — some, not all, of these are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
On this page
The verdict
Revel Health is more transparent on pricing than our last check had credited it for — per-product rates are shown right on the homepage, not gated behind a quiz. Its 45-state coverage claim checks out exactly, with the same five exclusions our last check recorded. The main gap is the same one our last check flagged: the compounding pharmacy itself is still never individually named, just described in general USP-compliance language.
Revel Health is not ranked on any of our rankings. This is a standalone read of what the company publishes about itself — the providers we do rank in this category are on our semaglutide provider ranking. Nothing on this page is a performance claim — see the evidence review for what these compounds do and do not do.
Who it is for, and who it is not
A good fit if
- You want to see pricing before starting an intake, not after
- You want GLP-1 combined with longevity add-ons (NAD+, sermorelin) on one platform
- You want a fast physician review — typically within the hour
Look elsewhere if
- You live in Alaska, Arkansas, North Carolina, New Jersey, or Mississippi — all confirmed excluded
- You want a named compounding pharmacy rather than general USP-compliance language
- You want brand-name GLP-1 options — this is compounded only
What it actually costs
What they advertise
Semaglutide: $99 the first month on myrevelhealth.com.
What you actually pay, month to month
$199/mo ongoing for semaglutide, $249/mo for tirzepatide.
The commitment trap
The $99 first-month price isn't the ongoing rate; semaglutide steps up to $199/mo from month two.
Checked live on Revel Health's own site at https://myrevelhealth.com in August 2026. Prices change without notice — confirm before you buy. Work out what a vial actually gives you with our peptide dose calculator.
What is included
The cheapest headline number in this category is often the one with the least attached to it. Here is what Revel Health bundles in, and what it does not.
Clinician consult
Physician review, typically within the hour.
Bloodwork / labs
Not published.
Follow-ups and dose changes
No cadence published.
Human support
Not published.
Injection supplies
Included in the flat price.
Shipping
Included in the flat price.
Pharmacy, labs and oversight
The pharmacy
Described only as "USP-compliant pharmacies"; no specific name disclosed.
Oversight
No cadence published.
Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Our guide to verifying a certificate of analysis covers what to ask for.
Where you can get it
45 states; excludes Alaska, Arkansas, North Carolina, New Jersey, and Mississippi.
The honest cons
The part they would rather you skipped
Revel Health's LegitScript badge and general "USP-compliant" language are both real, but the specific compounding pharmacy behind your medication is still never individually named anywhere on the site.
- Compounding pharmacy never individually named
- Excluded in 5 states (Alaska, Arkansas, North Carolina, New Jersey, Mississippi)
- Longevity add-ons (NAD+, sermorelin) add cost beyond the core GLP-1 program
- Compounded medications only — no brand-name option
None of this is unique to Revel Health — the whole category shares it. What we hold against a provider is the part it hides, and the ways vendors hide things are cataloged in our vendor red-flags guide.
How it compares
The providers we rank on our semaglutide provider ranking, in the order that ranking ranks them. Revel Health is not among them: it is reviewed here, not ranked there, and we would rather show you the comparison than pretend the two are the same thing.
- COCollectiveThe cheapest medication price here, on a membership the headline omits
- CoreAge RxOne price that does not move when your dose does
- BHBodybuilding Health+The deep peptide catalog is gone; the GLP-1 pricing got better
- RxSpan MDOral tablet only, at a real $179 monthly rate
- Enhance MDWrites a flat-price-at-every-dose policy down — and charges near the top for it
- Found HealthInsurance-integrated, unlike every cash-only compounder here — but $99 needs a prepay
- Direct MedsThe plainest price mechanics on either ranking, from a company with an FDA warning letter
- Synergy RxPublishes a starting number, and nothing about what it commits you to
13 more providers rank on our semaglutide provider ranking — see the full ranking. Every provider we review →
Read this before you buy
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Facts on this page reflect Revel Health's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on Revel Health's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.